IPSE'S AUTHORS LAST 24h
Check all the Authors in the last 24h
IPSEs IN THE LAST 24H
  • Tal Beeri
    Tal Beeri “So far, the IDF has not struck Hezbollah's significant systems. Even if the government pursues a diplomatic agreement, it will only postpone the war that will break out whenever Hezbollah chooses and on its terms-by my estimation, no later than the end of 2026. No political or diplomatic agreement will prevent Hezbollah from continuing to operate. Any such agreement only means buying time, with Israel being the only side likely to adhere to it, while Hezbollah waits for an opportune moment to initiate a full-scale confrontation.” 6 hours ago
  • Benjamin Netanyahu
    Benjamin Netanyahu “If we have to stand alone, we will stand alone. If we need to, we will fight with our fingernails. But we have much more than fingernails.” 13 hours ago
  • Sam Rose
    Sam Rose “People are petrified. People have been fearing this for a long, long time and it is now upon us. There is constant bombardment. There is smoke on the horizon. There are people on the move. Israel is subjecting Gaza to a medieval siege in a scorched earth war. No aid has come into Gaza now since Sunday. No aid, no fuel, no supplies, nothing. And we really are now down to our last reserves. We have a few more days of flour that we can provide. But everything else will start to shut down very soon without fuel, without water. So the situation is really desperate.” 13 hours ago
  • Shirley Yu
    Shirley Yu “Both trade and Russia are non-negotiable for China. Macron could not achieve anything [on those fronts]. Macron shares one vision in common with Xi, which is that the US hegemony - including the quest for Europe's allegiance to the US's foreign policy - must yield to a multipolar global order by accommodating the rising powers' interests and concerns. Macron's recent visits to India and Brazil also prove that France wants to stay at the forefront of that global shift.” 13 hours ago
  • Jason Straziuso
    Jason Straziuso “The food and water and medical supplies situation is critical and if this continues, then we move towards catastrophic, or even more catastrophic, consequences from the situation that we now see. International Committee of the Red Cross is constantly asking Israeli officials to allow access to humanitarian goods following the shutdown of the crossings. The Israeli officials know that we are desperate to bring in more supply trucks which we have waiting to cross the border as soon as they're able to. There's conversations also taking place about the need to spare civilian lives - no targeting of civilians, no targeting of civilian objects, meaning buildings, schools, medical facilities. Those talks have been happening for months.” 14 hours ago
  • Marwan Bishara
    Marwan Bishara “Something incredibly important is happening in the world today. Israel is getting a beating around the world, while Palestine is getting a beating in the Middle East. Palestine the cause - whether it's at the United Nations or Western capitals or university campuses - is certainly gaining ground.” 14 hours ago
View All IPSEs inserted in the Last 24h

Covid-19 vaccine

Page with all the IPSEs stored in the archive related to the Context Covid-19 vaccine.
The IPSEs are presented in chronological order based on when the IPSEs have been pronounced.

“With this vaccine [Chinese vaccine Sinopharm], five different types are now available in Hungary so that we may get as many people vaccinated as quickly as possible.”

author
Member of the Hungary National Public Health Center
Read More

“Given the outcomes of the efficacy studies [the government] will continue with the planned phase one vaccination using the Johnson & Johnson vaccines instead of the AstraZeneca vaccine. The Johnson & Johnson vaccine has been proven effective against the 501Y.V2 variant.”

author
South Africa Minister of Health
Read More

“Turning to Covax demonstrates the desperation of the Trudeau government in terms of its vaccine policy. Taking [vaccine supply] from a multilateral institution that was designed particularly to help the world's poor is shocking and an embarrassment.”

author
University of Toronto professor focused on global access to medicines
Read More

“The vaccines we have are very effective for individual protection and that's what we might expect, but you as an individual do not know whether you are completely protected or not. It is a 90 per cent vaccine effectiveness. You could be in the 10 per cent of the population that may have not taken to the vaccine. You still have to respect those public health measures. That is critical ... right now, the scientific principle underpinning the application of vaccines for international travel cannot be made ... because we do not know the vaccines reduce transmission.”

author
Canada's Chief Public Health Officer
Read More

“The arrival of the first vaccines is excellent news and a step in the right direction for South Africa. The most important point that should be emphasized is that while the vaccines offer variable efficacy in preventing infection with COVID-19, so far severe disease and death are prevented by all the vaccines. So it doesn't matter the level of efficacy, the vaccines all seem to work pretty well against severe disease and death, even against this new variant, it appears. And that is very good news.”

author
Director of the Africa Health Research Institute
Read More

“We all need to step into the place of them. Where they are today fighting on the front line... Fighting over the cake, when they don’t even have access to the crumbs. I think we need to stand back and think about our brave colleagues and where they stand today and what we are going to do about that.”

author
Head of WHO’s emergencies programme
Read More

“The real problem on AstraZeneca is that it doesn’t work the way we were expecting it to. We’re waiting for the EMA [European Medicines Agency] results, but today everything points to thinking it is quasi-ineffective on people older than 65, some say those 60 years or older.”

author
President of France
Read More

“We will continue to see the evolution of mutants. We will have to be nimble to adjust to make versions of the vaccine that are actually specifically directed to whatever mutations are prevalent at the time.”

author
Head of the National Institute of Allergy and Infectious Diseases
Read More

“Vaccinations are dangerous. If white people were able to come up with vaccinations, a vaccination for AIDS would have been found, a vaccination for tuberculosis could have eliminated it by now; a Malaria vaccine would have been found; a vaccination for cancer would have been found by now.”

author
President of Tanzania
Read More

“China will continue to push forward this vaccination scheme for high-risk people and then to the general public. The second half of 2021 would see all Chinese who would like to receive vaccines get a dose. Building herd immunity is something that should be considered in the second half of 2021.”

author
Shanghai-based medical expert on vaccines
Read More

“China is likely to reach the scheduled target since the country is deploying the vaccination in an orderly manner and vaccine producers also have sufficient supplies to guarantee the country to reach this goal.”

author
President of the China Vaccine Industry Association
Read More

“It’s just tremendously sad that we have so many people who want the vaccine and so much ability to give the vaccine, what’s happening? For lack of supply, we’re actually having to cancel appointments.”

author
Mayor of New York City
Read More

“We know that older people who have already been vaccinated in China and the Middle East have responded as well to the vaccines as younger people. So the argument that older people should not be vaccinated because they have not been included in trials in Indonesia is not valid. If you look at all the studies conducted in every country in the world, the evidence overwhelmingly shows the greatest risk factor for becoming gravely ill from COVID-19 is age. Even in Indonesia which has a young population, the most deaths are people over 60. So that makes me think about what my Indonesian colleagues have been telling me: that what the Indonesian government might really be trying to do is to achieve herd immunity by vaccinating young adults who are the most potent spreaders of the disease. But the problem with this strategy is that there is no evidence to suggest that vaccinations prevent recipients from acquiring and transmitting the disease. Effective vaccines have only been shown to prevent recipients from getting sick.”

author
Professor of vaccinology at the London School of Hygiene and Tropical Medicine who is based at the University of Melbourne
Read More

“Things are improving step by step, now more than 500,000 people have had the vaccine. If the approvals we expect come through for vaccines developed by AstraZeneca, CureVac or Johnson & Johnson, then in the summer Germany will be able to offer everyone a vaccine. We need patience. We have started the road out of this but a long path lies ahead.”

author
German Health Minister
Read More

“Imports of U.S. and British vaccines into the country are forbidden. I have told this to officials and I'm saying it publicly now. I really do not trust the United States and Britain. Sometimes they want to test their vaccines on other countries.”

author
Iran’s Supreme Leader
Read More

“mRNA vaccines can be quickly developed, they’re cheap, they’re effective, they appear safe, and you can adjust them by putting in a slightly different antigen if the virus changes its spots. But the overarching concern is, we’ve never used this type of vaccine before, so we have to do our darnedest to do the surveillance to check that it’s well tolerated.”

author
Infectious diseases and vaccine expert from the University of Sydney
Read More

“The reason it’s such a prolonged approval process in Australia and New Zealand is because there is lots of double checking and reexamining of the statistics, because if we make an error, it will become an error on a big scale by the time the drug is rolled out across a large population. It’s not that uncommon that the regulator might look at the data and say, 'Well, it looks OK in terms of how it works in European people, but we’re quite worried about how this might affect Indigenous people, and the Asian population seem to respond differently too'. Australia and New Zealand are saying; 'Why would you put people at risk when if you wait a bit longer, you can get more information?'”

author
Physician in Australia who is also a member of the pharmacology and therapeutics advisory committee of Pharmac, the sole purchaser for pharmaceuticals in New Zealand
Read More
May
MonTueWedThuFriSatSun
0102030405
06070809101112
13141516171819
20212223242526
2728293031
IPSEs by City
IPSEs by Author
IPSEs by Country
arrow